Vertera Spine

What Vertera Spine does

Vertera Spine is a private, for-profit medical device company founded in 2013 and headquartered in Atlanta, Georgia. The company is described as a medical platform aiming to commercialize and develop unique spine solutions, operating with a very small team of 1–10 employees. Its public-facing website is verteraspine.com. The company originated in an academic/research context, as evidenced by a $179,999 National Science Foundation grant awarded in 2014, and progressed through angel investment (Duke Angel Network, 2015) to a Series 2 financing of approximately $3.06 million in May 2017.

No specific products, regulatory clearances, clinical milestones, or named clinical/commercial customers are documented for Vertera Spine in the available data. The cumulative disclosed funding of roughly $3.24 million and a 1–10 employee band are consistent with an early-stage or pre-commercial stage entity. The most recent material recorded capital event dates to 2017, with no subsequent funding rounds, acquisitions, partnerships, product launches, or geographic expansion entries disclosed in the input. Pricing, go-to-market mechanics, and revenue model details are also absent from the source material.

It is important to distinguish Vertera Spine from Globus Medical, whose product portfolio, technology, customers, and AI capabilities constitute the bulk of the aggregated source data but are not attributes of Vertera Spine itself. As a result, the investable perimeter for analysis on Vertera Spine is narrow: a small, Atlanta-based, early-stage spine medical device company with research roots, modest angel/grant-funded history, and no documented commercial traction in the supplied data.

Name

Vertera Spine

Website

https://verteraspine.com

Company type

Private

Founded year

2013

Headcount range

1–10 employees

Short description

Vertera Spine is a private, Atlanta-based medical device company founded in 2013 that aims to develop and commercialize unique spine solutions. It operates with 1–10 employees and has raised approximately $3.24 million in cumulative disclosed funding.

Ownership category

akta.pro rank

Product category

Spinal Fusion Implants

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Spine Implants & Motion Preservation (Fusion/Disc/Interspinous) (HLAHAEAC)

Keywords

• Spine fusion implants
• Porous titanium technology
• Spinal medical devices
• Orthopedic implant solutions
• Spine surgery devices

Headquarters

HQ city

Atlanta

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales

Revenue model

1. Medical Device Hardware Sales: Sale of spine procedure solutions including access systems, interbody spacers, fixation systems, and regenerative biologics. Products are sold as medical devices to hospitals and surgical centers for spinal procedures.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Vertera Spine is a medical platform that aims to commercialize and develop unique spine solutions. The company focuses on proprietary Advanced Materials Science™ (AMS) porous implant technologies for spinal fusion procedures, including porous titanium and porous PEEK interbody devices designed to enhance osseointegration, bone ingrowth, and biomechanical compatibility.

Product overview

Globus Medical offers a comprehensive musculoskeletal solutions ecosystem centered on the Excelsius™ Technology platform, which integrates robotic navigation, augmented reality, and 3D imaging systems for spine, cranial, and orthopedic procedures. The portfolio includes multiple product categories: enabling technologies (ExcelsiusGPS™, ExcelsiusFlex™, ExcelsiusHub™, ExcelsiusXR™, Excelsius3D™), advanced materials science implants (Modulus™ porous titanium, HEDRON™ 3D-printed titanium, Cohere™ porous PEEK), regenerative biologics, power surgical instruments, and registry solutions (SpineTRACK™, OrthoTRACK™). The products work together as an integrated ecosystem designed to improve safety and care in the operating room.

Differentiator

Problem solved

Functional benefit

Products and services

• Modulus™ Porous titanium interbody implant technology featuring endplate porosity with an optimized body lattice structure, providing a fully porous architecture and a favorable environment for bone ingrowth. Enhances visualization compared to traditional titanium interbody implants in various imaging modalities. Available in a range of sizes and lordotic options for ALIF, XLIF™, TLIF, and cervical procedures.
• HEDRON™ 3D-printed titanium interbody spacers featuring a biomimetic porous scaffold designed to promote bone formation onto and through the implant. A preclinical ovine study showed significantly more bone growth compared to PEEK and titanium implants at 6 weeks postoperative.
• Cohere™ First-of-its-kind proprietary porous architecture for PEEK designed to promote bone ingrowth while maintaining the biomechanical and imaging properties of PEEK. Available in a dynamic range of heights and lordotic options for TLIF, XLIF™, and cervical procedures.

Quantifiable outcome

• Preclinical ovine study showed significantly more bone growth with HEDRON™ porous architecture compared to PEEK and titanium implants at 6 weeks postoperative

Segments3 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature3 records

Scale indicators1 record

Recent moves3 records

Expansion highlights2 records

Broad incumbents

• Medtronic (Spine & Biologics): Largest spine franchise globally with deep interbody, fixation, and enabling-technology portfolios. Comparable to Vertera as a broad incumbent that competes head-to-head on spinal fusion implants and sets the standard-of-care against which novel porous architectures must differentiate.
• DePuy Synthes (Johnson & Johnson MedTech): Spine division of J&J MedTech with broad interbody, fixation, and biologics offerings. Comparable to Vertera as a broad incumbent in spinal fusion with the scale to launch competing porous implant lines and dictate hospital contract terms.
• Stryker (Spine): Spine and ortho incumbent with interbody implant and enabling-technology lines. Comparable to Vertera as a broad incumbent competing in the same spinal fusion market with much larger sales and clinical evidence resources.
• Zimmer Biomet: Large orthopedic and spine company with interbody and biologics products. Comparable to Vertera as a broad incumbent with a diversified musculoskeletal portfolio that competes in the same hospital purchasing decisions.

Emerging players

• SI-BONE: Focused spine company commercializing implants for sacroiliac joint fusion, an adjacent spinal procedure category. Comparable to Vertera as a smaller, innovation-driven spine company targeting a defined fusion procedure with a single-platform commercial focus.

Direct peers

• Orthofix: Spine and orthopedic company with interbody fusion and biologics offerings. Comparable to Vertera in product category (spinal fusion hardware) and in operating with a mid-sized, spine-specialized commercial footprint.
• Globus Medical: Top-five musculoskeletal solutions company and the strategic acquirer/integrator of Vertera's porous implant technology. Directly comparable because Modulus, HEDRON, and Cohere are now commercialized as Globus spine products, and the company operates in the same spinal fusion interbody category with adjacent enabling-technology and biologics offerings.
• Spineart: Privately held spine company focused on interbody cages and fixation for cervical and lumbar fusion. Directly comparable to Vertera as a focused spine implant developer selling porous and surface-engineered cages into the same hospital and surgeon channels.
• Alphatec Spine: Spine-focused pure-play developing and commercializing a portfolio of interbody cages, fixation, and enabling technologies. Directly comparable to Vertera as a smaller, innovation-driven spine company targeting the same surgeon and hospital customers in spinal fusion.
• NuVasive: Pure-play spine company with a comprehensive interbody portfolio (including porous titanium and PEEK cages) for ALIF, TLIF, XLIF, and cervical fusion. Directly comparable to Vertera in product category, target surgeon customer, and spinal fusion GTM motion.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/vertera-inc-

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds3 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vertera Spine